<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073812458714</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073812458714</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correspondence</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Retinal Thickness in Pediatric Multiple Sclerosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yılmaz</surname>
<given-names>Ünsal</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073812458714">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073812458714"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gücüyener</surname>
<given-names>Kıvılcım</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073812458714">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Erin</surname>
<given-names>Döndü Melek</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0883073812458714">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yazar</surname>
<given-names>Zeliha</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0883073812458714">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gürkaş</surname>
<given-names>Esra</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073812458714">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Serdaroğlu</surname>
<given-names>Ayşe</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073812458714">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tepe</surname>
<given-names>Nermin</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-0883073812458714">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Demir</surname>
<given-names>Ercan</given-names>
</name>
<degrees>MD</degrees> <xref ref-type="aff" rid="aff2-0883073812458714">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883073812458714">
<label>1</label>Behçet Uz Children's Hospital, Alsancak, Izmir, Turkey</aff>
<aff id="aff2-0883073812458714">
<label>2</label>Department of Pediatric Neurology, Gazi University Medical Faculty, Ankara, Turkey</aff>
<aff id="aff3-0883073812458714">
<label>3</label>Department of Ophthalmology, Ankara Numune Hospital, Ankara, Turkey</aff>
<aff id="aff4-0883073812458714">
<label>4</label>Department of Neurology, Gazi University Medical Faculty, Ankara, Turkey</aff>
<author-notes>
<corresp id="corresp1-0883073812458714">Ünsal Yılmaz, Dr. Behçet Uz Children's Hospital Alsancak Izmir, 35210 Turkey Email: <email>drunsalyilmaz@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>12</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>12</issue>
<fpage>1621</fpage>
<lpage>1622</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Dear Editor,</p>
<p>We thank to Gundogan et al for their interest and contribution to our study. Our aim was mainly to determine whether there is a retinal thinning in pediatric patients with relapsing remitting multiple sclerosis and whether this atrophy is influenced by optic neuritis. We additionally compared visual evoked potential recordings between subgroups of eyes with and without previous optic neuritis.</p>
<p>Previously Gundogan et al<sup><xref ref-type="bibr" rid="bibr1-0883073812458714">1</xref></sup> reported increased visual evoked potential latencies and decreased amplitudes in adult multiple sclerosis patients without previous optic neuritis as compared to those of healthy controls. As we have not compared visual evoked potential recordings between patients and healthy controls, we could not confirm these results in the pediatric population. Instead, we compared visual evoked potential latency/amplitude values between subgroups and found that visual evoked potential amplitude was significantly reduced in the affected eyes of patients with previous optic neuritis as compared to patients without optic neuritis. However visual evoked potential latency was not found to be significantly different between patients with and without previous optic neuritis. When we performed these comparisons between groups stratified according to time interval from optic neuritis, although visual evoked potential latency was found to be more markedly delayed in patients with a longer time interval from clinical optic neuritis, this delay was not statistically significant, likely because of small sample size (<xref ref-type="table" rid="table1-0883073812458714">Table 1</xref>).</p>
<table-wrap id="table1-0883073812458714" position="float">
<label>Table 1.</label>
<caption>
<p>Comparisons of VEP Latency and Amplitudes Between Subgroups and Healthy Controls<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table1-0883073812458714" xlink:href="10.1177_0883073812458714-table1.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Eyes of patients without previous ON (<italic>n</italic> = 10)</th>
<th>Unaffected eyes of patients with previous ON (<italic>n</italic> = 7) </th>
<th>Affected eyes of patients with previous ON (<italic>n</italic> = 11) </th>
<th>Affected eyes of patients with time interval from ON ≥ 6 mo (<italic>n</italic> = 8)</th>
<th>Affected eyes of patients with time interval from ON ≥ 12 mo (<italic>n</italic> = 6)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Latency (ms)</td>
<td>116 (17)</td>
<td>115 (14)</td>
<td>119 (18)</td>
<td>125 (13)</td>
<td>128 (13)</td>
</tr>
<tr>
<td>
<italic>P</italic>
</td>
<td>
</td>
<td>.659</td>
<td>.524</td>
<td>.197</td>
<td>.174</td>
</tr>
<tr>
<td>Amplitude (µV)</td>
<td>14.2 (4.2)</td>
<td>9.71 (4.7)</td>
<td>8.14 (3.2)</td>
<td>7.25 (2.2)</td>
<td>7.50 (2.5)</td>
</tr>
<tr>
<td>
<italic>P</italic>
</td>
<td>
</td>
<td>.116</td>
<td>.009</td>
<td>.001</td>
<td>.004</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0883073812458714">
<p>Abbreviations: ON, optic neuritis; VEP, visual evoked potential.</p>
</fn>
<fn id="table-fn2-0883073812458714">
<p><sup>a</sup>Values are mean (standard deviation).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>We have already reported that mean retinal nerve fiber length thickness was reduced in eyes with delayed visual evoked potential latency as compared to eyes with normal visual evoked potential latency, though macular volume was not significantly different between the 2 groups.<sup><xref ref-type="bibr" rid="bibr2-0883073812458714">2</xref></sup> When we compared retinal nerve fiber layer thickness and macular volume between eyes of patients with normal and delayed visual evoked potential latency and healthy controls; mean and all 4 quadrant retinal nerve fiber layer thickness and macular volume were found significantly reduced in eyes with delayed visual evoked potential latency, whereas the reduction was significant only in temporal quadrant retinal nerve fiber layer thickness in patients with normal visual evoked potential latency (<xref ref-type="table" rid="table2-0883073812458714">Table 2</xref>).</p>
<table-wrap id="table2-0883073812458714" position="float">
<label>Table 2.</label>
<caption>
<p>Comparisons of Mean RNFL Thickness, Quadrant RNFL Thickness, and Macular Volume Values Between Eyes With Normal and Delayed VEP Latency Groups and Eyes of Healthy Controls<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table2-0883073812458714" xlink:href="10.1177_0883073812458714-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Eyes of controls (<italic>n</italic> = 30)</th>
<th>Eyes with normal VEP latency (<italic>n</italic> = 17)</th>
<th>Eyes with delayed VEP latency (<italic>n</italic> = 11) </th>
</tr>
</thead>
<tbody>
<tr>
<td>Mean RNFL thickness (µm) </td>
<td>98.0 (19.2)</td>
<td>89.3 (18.8)</td>
<td>72.1 (14.6)</td>
</tr>
<tr>
<td>
<italic>P</italic>
</td>
<td>
</td>
<td>.069</td>
<td>.001</td>
</tr>
<tr>
<td>Temporal quadrant RNFL thickness (µm)</td>
<td>74.6 (18.9)</td>
<td>58.7 (11.8)</td>
<td>57.7 (25.1)</td>
</tr>
<tr>
<td>
<italic>P</italic>
</td>
<td>
</td>
<td>.005</td>
<td>.033</td>
</tr>
<tr>
<td>Superior quadrant RNFL thickness (µm) </td>
<td>115.0 (20.5)</td>
<td>106.4 (22.2)</td>
<td>89.6 (20.2)</td>
</tr>
<tr>
<td>
<italic>P</italic>
</td>
<td>
</td>
<td>.211</td>
<td>.002</td>
</tr>
<tr>
<td>Nasal quadrant RNFL thickness (µm) </td>
<td>78.3 (21.5)</td>
<td>76.3 (25.5)</td>
<td>49.0 (17.3)</td>
</tr>
<tr>
<td>
<italic>P</italic>
</td>
<td>
</td>
<td>.419</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Inferior quadrant RNFL thickness (µm)</td>
<td>117.9 (29.2)</td>
<td>112.5 (27.1)</td>
<td>91.6 (26.7)</td>
</tr>
<tr>
<td>
<italic>P</italic>
</td>
<td>
</td>
<td>.618</td>
<td>.012</td>
</tr>
<tr>
<td>Macular volume (mm<sup>3</sup>) </td>
<td>6.91 (0.73)</td>
<td>6.52 (0.54)</td>
<td>6.43 (0.44)</td>
</tr>
<tr>
<td>
<italic>P</italic>
</td>
<td>
</td>
<td>.050</td>
<td>.003</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0883073812458714">
<p>Abbreviations: RNFL, retinal nerve fiber layer; VEP, visual evoked potential.</p>
</fn>
<fn id="table-fn4-0883073812458714">
<p><sup>a</sup>Values are mean (standard deviation).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>As Gundogan et al have requested, we performed correlations between retinal nerve fiber layer thickness/macular volume and visual evoked potential latency and amplitude values in eyes of patients with pediatric multiple sclerosis, and we found no significant correlations (<xref ref-type="table" rid="table3-0883073812458714">Table 3</xref>). Recently Gundogan et al have also reported no correlations in eyes of adult multiple sclerosis patients without previous optic neuritis. However when they have included healthy controls in the analysis, they found that P100 latency was significantly correlated to retinal nerve fiber layer average and retinal nerve fiber layer temporal thicknesses. As we have not performed electrophysiological recordings in healthy controls, we could not include retinal nerve fiber layer thickness/macular volume and visual evoked potential latency and amplitude values of controls in the correlation analysis. From this point of view, our study was not able to show the electrophysiological status of pediatric multiple sclerosis patients in comparison to healthy controls.</p>
<table-wrap id="table3-0883073812458714" position="float">
<label>Table 3.</label>
<caption>
<p>Correlations Between VEP Latency/Amplitude and RNFL Thickness and MV Results in Patients With Pediatric MS</p>
</caption>
<graphic alternate-form-of="table3-0883073812458714" xlink:href="10.1177_0883073812458714-table3.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">Comparisons </th>
<th colspan="2"> Latency</th>
<th colspan="2"> Amplitude </th>
</tr>
<tr>
<th>
<italic>r</italic><sup>a</sup>
</th>
<th>
<italic>P</italic><sup>b</sup>
</th>
<th>
<italic>r</italic><sup>a</sup>
</th>
<th>
<italic>P</italic><sup>b</sup>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mean RNFL thickness</td>
<td>–0.352</td>
<td>.108</td>
<td>–0.034</td>
<td>.880</td>
</tr>
<tr>
<td>Temporal quadrant RNFL thickness</td>
<td>–0.068</td>
<td>.762</td>
<td>–0.200</td>
<td>.371</td>
</tr>
<tr>
<td>Superior quadrant RNFL thickness </td>
<td>–0.109</td>
<td>.628</td>
<td> 0.006</td>
<td>.980</td>
</tr>
<tr>
<td>Nasal quadrant RNFL thickness </td>
<td>–0.377</td>
<td>.084</td>
<td> 0.026</td>
<td>.909</td>
</tr>
<tr>
<td>Inferior quadrant RNFL thickness </td>
<td>–0.382</td>
<td>.079</td>
<td> 0.043</td>
<td>.849</td>
</tr>
<tr>
<td>Macular volume </td>
<td> 0.016</td>
<td>.944</td>
<td>–0.049</td>
<td>.828</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0883073812458714">
<p>Abbreviations: MS, multiple sclerosis; MV, macular volume; RNFL, retinal nerve fiber layer; VEP, visual evoked potential.</p>
</fn>
<fn id="table-fn6-0883073812458714">
<p><sup>a</sup>Spearman rho correlation coefficient.</p>
</fn>
<fn id="table-fn7-0883073812458714">
<p><sup>b</sup>Correlation significance.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Further studies investigating the electrophysiological status of the patients with multiple sclerosis along with the studies of retinal nerve fiber layer thickness/macular volume to find out the subclinical involvement of visual pathways and the disease itself are needed.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073812458714">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gundogan</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Demirkaya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sobaci</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Is optical coherence tomography really a new biomarker candidate in multiple sclerosis? A structural and functional evaluation</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2007</year>;<volume>48</volume>:<fpage>5773</fpage>–<lpage>5781</lpage>.</citation>
</ref>
<ref id="bibr2-0883073812458714">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yilmaz</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Gücüyener</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Erin</surname>
<given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis</article-title>. <source>J Child Neurol</source>. <year>2012</year>. <comment>doi:10.1177/0883073812447683</comment>.</citation>
</ref>
</ref-list>
</back>
</article>